Clinical relevance of plasma miR-106b levels in patients with chronic obstructive pulmonary disease

International Journal of Molecular Medicine

Volumn 31, Issue 3, 2013, Pages 533-539

  Soeda, Seiko ^a   Ohyashiki, Junko H ^a   Ohtsuki, Kazushige ^a   Umezu, Tomohiro ^a   Setoguchi, Yasuhiro ^a   Ohyashiki, Kazuma ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Chronic obstructive pulmonary disease; MicroRNA; MiR 106b; Plasma; Smoking

Indexed keywords

MICRORNA; MICRORNA 101; MICRORNA 106B; MICRORNA 133B; MICRORNA 152; MICRORNA 26B; MICRORNA 29B; MICRORNA 483 5P; MICRORNA 532 5P; MICRORNA 629; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DOWN REGULATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE EXPRESSION PROFILING; HUMAN; MALE; MICRORNA BLOOD LEVEL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; SMOKING;

FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEUTROPHILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; ROC CURVE; SMOKING; TRANSFORMING GROWTH FACTOR BETA;

EID: 84873147531     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1251     Document Type: Article

References (33)

1. Agusti A and Soriano JB: COPD as a systemic disease. COPD 5: 133-138, 2008.
2. Fabbri LM, Luppi F, Beghe B and Rabe KF: Complex chronic comorbidities of COPD. Eur Respir J 31: 204-212, 2008.
3. Celli BR, Cote CG, Marin JM, et al: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350: 1005-1012, 2004.
4. Barnes PJ and Celli BR: Systemic manifestations and comorbidities of COPD. Eur Respir J 33: 1165-1185, 2009.
5. Sinden NJ and Stockley RA: Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence. Thorax 65: 930-936, 2010.
6. Decramer M, Janssens W and Miravitlles M: Chronic obstructive pulmonary disease. Lancet 379: 1341-1351, 2012.
7. Chen HY, Yu SL, Li KC and Yang PC: Biomarkers and transcriptome profiling of lung cancer. Respirology 17: 620-626, 2012.
8. Katoh Y and Katoh M: Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA (Review). Int J Mol Med 22: 271-275, 2008.
9. Lee EM, Shin S, Cha HJ, et al: Suberoylanilide hydroxamic acid (SAHA) changes microRNA expression profiles in A549 human non-small cell lung cancer cells. Int J Mol Med 24: 45-50, 2009.
10. Mitchell PS, Parkin RK, Kroh EM, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518, 2008.
11. Etheridge A, Lee I, Hood L, Galas D and Wang K: Extracellular microRNA: a new source of biomarkers. Mutat Res 717: 85-90, 2011.
12. Ezzie ME, Crawford M, Cho JH, et al: Gene expression networks in COPD: microRNA and mRNA regulation. Thorax 67: 122-131, 2011.
13. Schembri F, Sridhar S, Perdomo C, et al: MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci USA 106: 2319-2324, 2009.
14. Hunter MP, Ismail N, Zhang X, et al: Detection of microRNA expression in human peripheral blood microvesicles. PloS One 3: e3694, 2008.
15. Ohyashiki JH, Umezu T, Kobayashi C, et al: Impact on cell to plasma ratio of miR-92a in patients with acute leukemia: in vivo assessment of cell to plasma ratio of miR-92a. BMC Res Notes 3: 347, 2010.
16. Yoshizawa S, Ohyashiki JH, Ohyashiki M, et al: Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders. Blood Cancer J 2: e53, 2012.
17. Vestbo J and Rennard S: Chronic obstructive pulmonary disease biomarker(s) for disease activity needed urgently. Am J Respir Crit Care Med 182: 863-864, 2010.
18. Han MK: Update in chronic obstructive pulmonary disease in 2010. Am J Respir Crit Care Med 183: 1311-1315, 2011.
19. Sakao S and Tatsumi K: The importance of epigenetics in the development of chronic obstructive pulmonary disease. Respirology 16: 1056-1063, 2011.
20. Pottelberge GR, Mestdagh P, Bracke KR, et al: MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 183: 898-906, 2011.
21. Sato T, Liu X, Nelson A, et al: Reduced miR-146a increases prostaglandin E in chronic obstructive pulmonary disease fibroblasts. Am J Respir Crit Care Med 182: 1020-1029, 2010.
22. Lewis A, Riddoch-Contreras J, Natanek SA, et al: Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD. Thorax 67: 26-34, 2012.
23. Izzotti A, Calin GA, Arrigo P, Steele VE, Croce CM and De Flora S: Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J 23: 806-812, 2012.
24. Cushing L, Kuang PP, Qian J, et al: miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol 45: 287-294, 2011.
25. Akbas F, Coskunpinar E, Aynaci E, Oltulu YM and Yildiz P: Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease. Exp Lung Res 38: 286-294, 2012.
26. Rutgers SR, Postma DS, ten Hacken NH, et al: Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 55: 12-18, 2000.
27. Lapperre TS, Postma DS, Gosman MM, et al: Relation between duration of smoking cessation and bronchial inflammation in COPD. Thorax 61: 115-121, 2006.
28. Margadant C and Sonnenberg A: Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing. EMBO Rep 11: 97-105, 2010.
29. Takizawa H, Tanaka M, Takami K, et al: Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 163: 1476-1483, 2001.
30. Mak JC, Chan-Yeung MM, Ho SP, et al: Elevated plasma TGF-beta1 levels in patients with chronic obstructive pulmonary disease. Respir Med 103: 1083-1089, 2009.
31. Gong Y, Fan L, Wan H, et al: Lack of association between the TGF-β(1) gene and development of COPD in Asians: a case-control study and meta-analysis. Lung 189: 213-223, 2011.
32. Marwick JA, Kirkham P, Gilmour PS, Donaldson K, Mac NW and Rahman I: Cigarette smoke-induced oxidative stress and TGF-beta1 increase p21waf1/cip1 expression in alveolar epithelial cells. Ann NY Acad Sci 973: 278-283, 2002.
33. Ivanovska I, Ball AS, Diaz RL, et al: MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 28: 2167-2174, 2008.